Literature DB >> 23857294

Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patients.

E Scott Halstead1, Joseph A Carcillo, Bastian Schilling, Robert J Greiner, Theresa L Whiteside.   

Abstract

BACKGROUND: Sepsis continues to be a leading cause of death in infants and children. Natural killer (NK) cells serve as a bridge between innate and adaptive immunity, yet their role in pediatric sepsis has not been well characterized.
METHODS: We tested the hypothesis that decreased NK cell cytotoxicity is a common feature of pediatric systemic inflammatory response syndrome (SIRS)/sepsis patients by measuring, using flow cytometry, NK cell cytotoxicity and cell surface phenotype in the peripheral blood of 38 pediatric intensive care patients who demonstrated signs and symptoms of SIRS and/or sepsis.
RESULTS: NK cell cytotoxicity was significantly reduced in peripheral blood mononuclear cells (PBMCs) of pediatric SIRS/sepsis patients as compared with healthy controls, and the percentage of CD56(dim) CD16(+) cytotoxic NK cells in PBMCs was lower in patients with SIRS/sepsis than in normal donors. However, on a per cell basis, CD56(dim) CD16(+) NK cells in patients mediated cytotoxicity as well as those in normal donors.
CONCLUSION: The NK cell dysfunction in pediatric SIRS/sepsis patients reflects a quantitative rather than a qualitative difference from healthy controls.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23857294     DOI: 10.1038/pr.2013.121

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  14 in total

1.  Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis syndrome*.

Authors:  Dennis W Simon; Rajesh Aneja; Joseph A Carcillo; E Scott Halstead
Journal:  Pediatr Crit Care Med       Date:  2014-06       Impact factor: 3.624

Review 2.  Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

Authors:  Matthew J Delano; Peter A Ward
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

Review 3.  Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  Joseph A Carcillo; Bradley Podd; Rajesh Aneja; Scott L Weiss; Mark W Hall; Timothy T Cornell; Thomas P Shanley; Lesley A Doughty; Trung C Nguyen
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

Review 4.  The immune system's role in sepsis progression, resolution, and long-term outcome.

Authors:  Matthew J Delano; Peter A Ward
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

5.  Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome.

Authors:  Joseph A Carcillo; E Scott Halstead; Mark W Hall; Trung C Nguyen; Ron Reeder; Rajesh Aneja; Bita Shakoory; Dennis Simon
Journal:  Pediatr Crit Care Med       Date:  2017-06       Impact factor: 3.624

6.  How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.

Authors:  Joseph A Carcillo; Dennis W Simon; Bradley S Podd
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

7.  Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study.

Authors:  Elisabet Bergsten; AnnaCarin Horne; Ida Hed Myrberg; Maurizio Aricó; Itziar Astigarraga; Eiichi Ishii; Gritta Janka; Stephan Ladisch; Kai Lehmberg; Kenneth L McClain; Milen Minkov; Vasanta Nanduri; Diego A Rosso; Elena Sieni; Jacek Winiarski; Jan-Inge Henter
Journal:  Blood Adv       Date:  2020-08-11

8.  Hyperferritinemic Sepsis: An Opportunity for Earlier Diagnosis and Intervention?

Authors:  E Scott Halstead; Surender Rajasekaran; Julie C Fitzgerald; Scott L Weiss
Journal:  Front Pediatr       Date:  2016-08-02       Impact factor: 3.418

9.  Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study.

Authors:  Solenn Remy; Karine Kolev-Descamps; Morgane Gossez; Fabienne Venet; Julie Demaret; Etienne Javouhey; Guillaume Monneret
Journal:  Ann Intensive Care       Date:  2018-03-13       Impact factor: 6.925

10.  Case Report: Rapid Recognition and Immune Modulation of Secondary HLH Due to Disseminated HSV Infection.

Authors:  Daniel J McKeone; Theodore K M DeMartini; Robert P Kavanagh; E Scott Halstead
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.